BCR-ABL Mutation-Guided Therapy for CML Blast Crisis: A Case Report

Benjamin N Ostendorf1, Hendrik Nogai2, Claudia D Baldus1

  • 1Charité University Medicine, Department of Hematology, Oncology and Tumor Immunology, Berlin, Germany.

Biomarker Insights
|September 18, 2015
PubMed
Summary

Managing advanced chronic myeloid leukemia (CML) is complex. This case study highlights integrating targeted therapy, chemotherapy, and stem cell transplantation for CML in mixed phenotype blast phase.